Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02106546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of the addition of veliparib plus carboplatin and paclitaxel versus the addition of placebo plus carboplatin and paclitaxel in adults with advanced or metastatic squamous non-small cell lung cancer (NSCLC).
Study identification
- NCT ID
- NCT02106546
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 970 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 10, 2014 (Actual)
- Primary completion
- Jan 3, 2017 (Actual)
- Completion
- Nov 20, 2019 (Actual)
- Last update posted
- Nov 17, 2020
2014 – 2019
United States locations
- U.S. sites
- 38
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northeast Arkansas Clinical Ch /ID# 128071 | Jonesboro | Arkansas | 72401 | — |
| LA Hem-Oncology Med Group /ID# 129178 | Los Angeles | California | 90017 | — |
| VA Eastern Colorado Healthcare System /ID# 128065 | Aurora | Colorado | 80045 | — |
| Holy Cross Hospital /ID# 128074 | Fort Lauderdale | Florida | 33308 | — |
| University of Florida - Archer /ID# 126476 | Gainesville | Florida | 32610 | — |
| Cancer Specialists of North Florida - Southpoint /ID# 127815 | Jacksonville | Florida | 32256 | — |
| Winship Cancer Institute of Emory University /ID# 124061 | Atlanta | Georgia | 30322-1013 | — |
| St. Luke's Mountain States Tumor Institute - Boise /ID# 124059 | Boise | Idaho | 83712 | — |
| Illinois Cancer Specialists /ID# 127468 | Arlington Heights | Illinois | 60005 | — |
| NorthShore University HealthSystem - Evanston Hospital /ID# 128585 | Evanston | Illinois | 60201 | — |
| Ingalls Memorial Hosp /ID# 128360 | Harvey | Illinois | 60426 | — |
| Midwestern Regional CTC /ID# 126124 | Zion | Illinois | 60099 | — |
| Goshen Center for Cancer Care /ID# 123875 | Goshen | Indiana | 46526 | — |
| Franciscan St. Francis Health /ID# 126678 | Indianapolis | Indiana | 46237 | — |
| Appalachian Regional Healthcare, Inc (ARH) /ID# 128061 | Hazard | Kentucky | 41701 | — |
| Henry Ford Health System /ID# 126500 | Detroit | Michigan | 48202 | — |
| Sparrow Regional Cancer Center, Sparrow Health System /ID# 127156 | Lansing | Michigan | 48912 | — |
| Minnesota Oncology Hematology, PA /ID# 127473 | Minneapolis | Minnesota | 55404 | — |
| Nebraska Hematology Oncology /ID# 127699 | Lincoln | Nebraska | 68506 | — |
| SE Nebraska Hema/Oncology Consultants P.C.d/b/a Southeast Nebraska Cancer Center /ID# 126477 | Lincoln | Nebraska | 68510 | — |
| Comprehensive Cancer Ctrs Neva /ID# 127491 | Las Vegas | Nevada | 89169 | — |
| Dartmouth-Hitchcock Medical Center /ID# 128075 | Lebanon | New Hampshire | 03756 | — |
| Hackensack Univ Med Ctr /ID# 124057 | Hackensack | New Jersey | 07601 | — |
| Gabrail Cancer Center Research /ID# 127415 | Canton | Ohio | 44718 | — |
| Penn State University and Milton S. Hershey Medical Center /ID# 126676 | Hershey | Pennsylvania | 17033 | — |
| The Jones Clinic, PC /ID# 124062 | Germantown | Tennessee | 38138 | — |
| Texas Oncology - Austin Midtown /ID# 127477 | Austin | Texas | 78705 | — |
| Texas Oncology - South Austin /ID# 127476 | Austin | Texas | 78745 | — |
| Parkland Health and Hosp Syste /ID# 128518 | Dallas | Texas | 75235 | — |
| Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 128385 | Dallas | Texas | 75246-2003 | — |
| UT Southwestern Medical Center /ID# 127876 | Dallas | Texas | 75390-7208 | — |
| University of Texas MD Anderson Cancer Center /ID# 127946 | Houston | Texas | 77030 | — |
| Texas Oncology - Paris /ID# 127484 | Paris | Texas | 75460 | — |
| Texas Oncology - Waco /ID# 127459 | Waco | Texas | 76712 | — |
| University of Vermont Medical Center /ID# 128064 | Burlington | Vermont | 05401-1473 | — |
| Virginia Oncology Associates /ID# 127458 | Norfolk | Virginia | 23502 | — |
| Northwest Cancer Specialists, P.C. /ID# 127486 | Vancouver | Washington | 98684 | — |
| Northwest Cancer Specialists, P.C. /ID# 127488 | Vancouver | Washington | 98684 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 187 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02106546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02106546 live on ClinicalTrials.gov.